prazosin has been researched along with Coronary Artery Disease in 2 studies
Prazosin: A selective adrenergic alpha-1 antagonist used in the treatment of HEART FAILURE; HYPERTENSION; PHEOCHROMOCYTOMA; RAYNAUD DISEASE; PROSTATIC HYPERTROPHY; and URINARY RETENTION.
prazosin : A member of the class of piperazines that is piperazine substituted by a furan-2-ylcarbonyl group and a 4-amino-6,7-dimethoxyquinazolin-2-yl group at positions 1 and 4 respectively.
Coronary Artery Disease: Pathological processes of CORONARY ARTERIES that may derive from a congenital abnormality, atherosclerotic, or non-atherosclerotic cause.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Piatak, OA | 1 |
Yanovskii, GV | 1 |
Lizogub, VG | 1 |
Morozova, TE | 1 |
1 trial available for prazosin and Coronary Artery Disease
Article | Year |
---|---|
The influence of adrenoreactive preparations on clinical and haemodynamic parameters in patients with ischaemic heart disease.
Topics: Adult; Angina Pectoris; Coronary Artery Disease; Coronary Disease; Double-Blind Method; Exercise Tes | 1991 |
1 other study available for prazosin and Coronary Artery Disease
Article | Year |
---|---|
[Use of prazosin in the treatment of heart failure in patients with post-infarction cardiosclerosis].
Topics: Adult; Aged; Cardiomyopathy, Dilated; Coronary Artery Disease; Female; Hemodynamics; Humans; Male; M | 1990 |